logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Market News
Filter

Market News

Categories

Sectors

Locations

Exchange

美国雅培新冠肺炎诊断试剂获FDA紧急使用授权

With new FDA approval, Abbott sets goal of shipping 1 million coronavirus tests per week

Mar 20, 2020

Life Science

世卫组织:正在研制至少20种新冠病毒疫苗,确保人人接种

WHO officials say at least 20 coronavirus vaccines are in development in global race for cure

Mar 20, 2020

Life Science

梯瓦制药 冠状病毒 疟疾药物,意大利 疫情

Healthcare Roundup – Teva to donate 6M doses of malaria drug for coronavirus use, Italy now world’s #1 Covid-19 hotspot

Mar 20, 2020

Life Science

苹果 5G iPhone 亚马逊 Prime Pantry

Technology Roundup – Apple’s 5G iPhones currently on schedule, Amazon pauses Pantry deliveries

Mar 19, 2020

Technology

新冠病毒 中国 疫苗 试验

First-Phase Clinical Trials of China’s First Covid-19 Vaccine to Last Nine Months

Mar 19, 2020

Life Science

香港 狗 新冠病毒 渔护署

Hong Kong’s Authorities were notified by the owner of the 17-year old Pomeranian that the dog had died on Monday

Mar 19, 2020

Life Science

黄金仍然是表现最好的资产之一

Gold still among best-performing assets despite recent volatility

Mar 19, 2020

Mining, Precious Metals

法维拉韦获治疗新冠病毒推荐,海正药业走红

Favilavir’s Covid-19 Effectiveness Boosts Hisun Pharma, Fujifilm Stock to Limit

Mar 19, 2020

Life Science

特朗普 病毒 吉利德Covid-19药物

Healthcare Roundup – Trump invokes Defense Production Act in response to virus, Gilead’s Covid-19 drug may get quick FDA approval

Mar 18, 2020

Technology

Technology Roundup – Harnessing location data to combat coronavirus, AT&T temporarily shuts 40% of retail stores

Mar 18, 2020

Technology

再鼎医药 则乐(尼拉帕利) 卵巢癌

(Niraparib) for First-Line Maintenance Treatment of Ovarian Cancer in China by the NMPA

Mar 18, 2020

Life Science

康希诺 Moderna 新冠病毒

China’s CanSino pushes coronavirus vaccine into clinical testing as Moderna kicks off trial

Mar 18, 2020

Life Science

Health Catalyst 亚马逊 新冠病毒 COVID-19

Technology Roundup – Health Catalyst up 4% on COVID-19 offerings, Amazon suspends non-essential shipments to warehouses

Mar 18, 2020

Technology

艾伯维 艾尔健 Qiagen RNA提取试剂盒 新冠病毒测试

Healthcare Roundup – AbbVie and Allergan ink agreement, Qiagen to ramp up production of RNA extraction kits for coronavirus tests

Mar 18, 2020

Life Science

波音 政府援助 新冠病毒

Boeing seeks $60 billion in government aid for aerospace industry hit by coronavirus

Mar 17, 2020

Technology

诺诚健华 香港上市

China biotech InnoCare raises $288 million in Hong Kong IPO: sources

Mar 17, 2020

Life Science

应世生物IN10018

InxMed Announces Dosing of First Patient in a Phase Ib Trial of IN10018 as Monotherapy and Combination Therapy in Patients with Uveal Melanoma and NRAS mutant Metastatic Melanoma in the United States

Mar 17, 2020

Life Science

谷歌 COVID-19测试 京东香港上市

Technology Roundup – Google clarifies COVID-19 test efforts, JD.com hires bankers to pursue Hong Kong listing

Mar 17, 2020

Technology

  • ‹‹ Previous
  • 270
  • 271
  • 272
  • 273
  • 274
  • 275
  • 276
  • 277
  • 278
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada